Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68 | Clinical Pharmacist | journal | 0.101 Q4 | 11 | 68 | 197 | 373 | 1 | 130 | 0.00 | 5.49 |  |
| 67 | Drugs and Therapy Perspectives | journal | 0.105 Q4 | 13 | 71 | 214 | 1667 | 10 | 212 | 0.07 | 23.48 | |
| 66 | PharmacoEconomics - Italian Research Articles | journal | 0.111 Q4 | 9 | 2 | 46 | 91 | 1 | 37 | 0.00 | 45.50 | |
| 65 | Clinical Practice | journal | 0.126 Q4 | 10 | 82 | 148 | 4462 | 25 | 124 | 0.17 | 54.41 | |
| 64 | Drug and Therapeutics Bulletin | journal | 0.147 Q3 | 17 | 138 | 418 | 901 | 37 | 95 | 0.09 | 6.53 | |
| 63 | Therapy | journal | 0.159 Q3 | 22 | 0 | 73 | 0 | 24 | 66 | 0.00 | 0.00 | |
| 62 | Klinik Psikofarmakoloji Bulteni | journal | 0.165 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 61 | Expert Opinion on Orphan Drugs | journal | 0.191 Q3 | 27 | 130 | 100 | 8468 | 52 | 100 | 0.52 | 65.14 | |
| 60 | MeReC Bulletin | journal | 0.192 Q3 | 7 | 0 | 6 | 0 | 1 | 2 | 0.00 | 0.00 | |
| 59 | Pharmaceutical Medicine | journal | 0.246 Q3 | 25 | 21 | 62 | 453 | 53 | 57 | 0.62 | 21.57 | |
| 58 | Therapeutic Advances in Drug Safety | journal | 0.360 Q3 | 46 | 21 | 70 | 1183 | 78 | 66 | 1.06 | 56.33 | |
| 57 | Journal of Oncology Pharmacy Practice | journal | 0.418 Q3 | 44 | 94 | 196 | 2203 | 302 | 189 | 1.43 | 23.44 | |
| 56 | Journal of Chemotherapy | journal | 0.518 Q2 | 56 | 76 | 202 | 1953 | 334 | 170 | 1.79 | 25.70 | |
| 55 | Clinical Drug Investigation | journal | 0.621 Q2 | 67 | 95 | 333 | 2594 | 698 | 317 | 2.00 | 27.31 | |
| 54 | Biopharmaceutics and Drug Disposition | journal | 0.637 Q2 | 65 | 48 | 149 | 2036 | 418 | 143 | 2.73 | 42.42 | |
| 53 | Therapeutic Advances in Cardiovascular Disease | journal | 0.686 Q2 | 41 | 24 | 76 | 1022 | 132 | 63 | 1.66 | 42.58 | |
| 52 | International Journal of STD and AIDS | journal | 0.688 Q2 | 78 | 173 | 660 | 4275 | 854 | 615 | 1.12 | 24.71 | |
| 51 | Fundamental and Clinical Pharmacology | journal | 0.700 Q2 | 85 | 73 | 242 | 3202 | 541 | 242 | 2.26 | 43.86 | |
| 50 | BMC pharmacology & toxicology | journal | 0.715 Q2 | 43 | 77 | 83 | 2511 | 191 | 79 | 2.30 | 32.61 | |
| 49 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.738 Q2 | 81 | 111 | 318 | 3633 | 730 | 315 | 2.26 | 32.73 | |
| 48 | Expert Opinion on Pharmacotherapy | journal | 0.764 Q2 | 93 | 243 | 750 | 16898 | 2033 | 718 | 2.91 | 69.54 | |
| 47 | Paediatric Drugs | journal | 0.777 Q2 | 70 | 49 | 134 | 3691 | 320 | 127 | 2.43 | 75.33 | |
| 46 | European Journal of Contraception and Reproductive Health Care | journal | 0.782 Q2 | 53 | 61 | 179 | 1332 | 322 | 170 | 1.55 | 21.84 | |
| 45 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.783 Q2 | 61 | 89 | 248 | 4509 | 532 | 233 | 1.97 | 50.66 | |
| 44 | Human Psychopharmacology | journal | 0.818 Q2 | 86 | 72 | 245 | 3003 | 625 | 234 | 2.66 | 41.71 | |
| 43 | Expert Review of Anticancer Therapy | journal | 0.850 Q2 | 85 | 159 | 521 | 11084 | 1112 | 491 | 2.30 | 69.71 | |
| 42 | Expert Review of Clinical Pharmacology | journal | 0.870 Q2 | 60 | 100 | 218 | 6825 | 535 | 185 | 2.18 | 68.25 | |
| 41 | BioDrugs | journal | 0.875 Q2 | 79 | 48 | 146 | 2839 | 412 | 144 | 3.40 | 59.15 | |
| 40 | BMC Clinical Pharmacology | journal | 0.883 Q2 | 43 | 0 | 37 | 0 | 113 | 37 | 3.29 | 0.00 | |
| 39 | AIDS Research and Therapy | journal | 0.924 Q2 | 49 | 39 | 113 | 1262 | 241 | 112 | 1.84 | 32.36 | |
| 38 | BMC Pharmacology | journal | 0.968 Q2 | 48 | 0 | 22 | 0 | 59 | 22 | 4.00 | 0.00 | |
| 37 | Therapeutic Advances in Respiratory Disease | journal | 0.974 Q2 | 50 | 20 | 99 | 763 | 270 | 93 | 2.42 | 38.15 | |
| 36 | Expert Opinion on Emerging Drugs | journal | 0.982 Q2 | 54 | 41 | 129 | 3944 | 391 | 126 | 3.18 | 96.20 | |
| 35 | American Journal of Cardiovascular Drugs | journal | 0.992 Q2 | 60 | 40 | 133 | 2536 | 350 | 123 | 2.60 | 63.40 | |
| 34 | Expert Opinion on Drug Safety | journal | 0.992 Q2 | 90 | 165 | 262 | 10875 | 873 | 256 | 3.44 | 65.91 | |
| 33 | Cardiovascular Therapeutics | journal | 1.051 Q1 | 54 | 46 | 203 | 1736 | 552 | 194 | 2.75 | 37.74 | |
| 32 | Acta Pharmacologica Sinica | journal | 1.054 Q1 | 117 | 163 | 586 | 5725 | 1508 | 571 | 2.66 | 35.12 | |
| 31 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.061 Q1 | 57 | 56 | 168 | 3331 | 457 | 163 | 2.55 | 59.48 | |
| 30 | Expert Review of Neurotherapeutics | journal | 1.069 Q1 | 98 | 147 | 476 | 13542 | 1421 | 438 | 2.85 | 92.12 | |
| 29 | Trials | journal | 1.117 Q1 | 98 | 509 | 954 | 21114 | 2226 | 932 | 2.12 | 41.48 | |
| 28 | Antimicrobial Resistance and Infection Control | journal | 1.178 Q1 | 66 | 37 | 64 | 1046 | 233 | 54 | 3.64 | 28.27 | |
| 27 | Drug Safety | journal | 1.238 Q1 | 140 | 95 | 321 | 4352 | 1058 | 282 | 3.30 | 45.81 | |
| 26 | Pharmaceutical Statistics | journal | 1.276 Q1 | 46 | 46 | 193 | 880 | 295 | 177 | 0.94 | 19.13 | |
| 25 | Drugs and Aging | journal | 1.330 Q1 | 109 | 87 | 284 | 5042 | 998 | 264 | 3.58 | 57.95 | |
| 24 | HIV Clinical Trials | journal | 1.338 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 23 | Journal of Biomedical Science | journal | 1.381 Q1 | 110 | 101 | 295 | 4558 | 1021 | 295 | 3.24 | 45.13 | |
| 22 | Expert Opinion on Investigational Drugs | journal | 1.431 Q1 | 117 | 140 | 442 | 11529 | 1741 | 434 | 4.18 | 82.35 | |
| 21 | British Journal of Clinical Pharmacology | journal | 1.487 Q1 | 167 | 273 | 758 | 10601 | 2837 | 610 | 3.64 | 38.83 | |
| 20 | Antiviral Therapy | journal | 1.541 Q1 | 93 | 107 | 473 | 3662 | 1522 | 455 | 3.13 | 34.22 | |
| 19 | CNS Neuroscience and Therapeutics | journal | 1.619 Q1 | 91 | 149 | 398 | 6211 | 1442 | 306 | 3.37 | 41.68 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data